The combined use of disease activity and infliximab serum trough concentrations for early prediction of (non-)response to infliximab in rheumatoid arthritis

समान संसाधन

• Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
  द्वारा: van der Maas, Aatke, और अन्य
  प्रकाशित: (2012)
• Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study
  द्वारा: van den Bemt, Bart JF, और अन्य
  प्रकाशित: (2011)
• Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study
  द्वारा: den Broeder, Alfons A, और अन्य
  प्रकाशित: (2013)
• Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity
  द्वारा: Verhoef, Lise M, और अन्य
  प्रकाशित: (2019)
• What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors?
  द्वारा: Bouman, Chantal A M, और अन्य
  प्रकाशित: (2017)